Niagen Bioscience, Inc. · NASDAQ:NAGE
The Vanguard Group reported a 5.04% stake in Niagen Bioscience, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Oct 31, 2025
The Vanguard Group reported a 5.04% stake in Niagen Bioscience, Inc., 4,021,650 shares, as a passive investor on Sep 30, 2025. Filed Oct 31, 2025 (Schedule 13G).
- Stake
- 5.04%
- Shares
- 4,021,650
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.04% | 4,021,650 |
Source
Related
- Niagen Bioscience, Inc.
- The Vanguard Group
- Niagen Bioscience, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Jan 30, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Lopez Carlos Luis · Jul 8, 2026
- Form 4 · Pamir Ozan · Jul 8, 2026
- Form 4 · Fried Robert N · Jul 8, 2026
- Form 4 · Fried Robert N · Apr 27, 2026